QLGN - Qualigen Therapeutics GAAP EPS of -$0.10 beats by $0.06 revenue of $1.44M misses by $0.18M November, 15 2022 07:42 AM Qualigen Therapeutics Inc. Qualigen Therapeutics press release ( NASDAQ: QLGN ): Q3 GAAP EPS of -$0.10 beats by $0.06 . Revenue of $1.44M (+24.1% Y/Y) misses by $0.18M . For further details see: Qualigen Therapeutics GAAP EPS of -$0.10 beats by $0.06, revenue of $1.44M misses by $0.18M